Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of phenylacetate in treating children with recurrent or progressive brain tumors.

Key facts

Study ID

NCT00003241

Run by

Texas Children's Cancer Center

Starts

1998-05-01

Expected to finish

2004-09-01

Last updated by the study team

2013-06-26

Who can join

Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Hospital Los Angeles — Los Angeles, California, United States
• UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• Pediatric Oncology Branch — Bethesda, Maryland, United States
• Cleveland Clinic Cancer Center — Cleveland, Ohio, United States
• Texas Children's Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.